The IMA (Investment Management Association) commissioned CRA to undertake an independent appraisal of both the potential impact of the FSA’s proposals set out in CP1761 and the cost-benefit analysis undertaken for the FSA by OXERA2. In particular, CRA was asked to examine in more detail: how these proposals might be implemented in practice; how the detail of their rules could affect the market outcome; and whether there were alternative proposals also worthy of further consideration.
Earnouts in M&A: Risk allocation, incentives, and post-closing disputes
He examines a recent Delaware Supreme Court case between Johnson & Johnson and Auris Health, Inc., illustrating how courts would uphold the negotiated terms of...